A comparison of patients with liver cancer receiving palliative care at two Veterans Affairs (VA) Medical Centers.

Authors

null

Sarah Lee

Rutgers New Jersey Medical School, Newark, NJ

Sarah Lee, Zhen Wang, Sejal Kothadia, Yucai Wang, Ellen Olson, Yeun-Hee Anna Park, David Klein, Fengming Zhong, Victor Tsu-Shih Chang

Organizations

Rutgers New Jersey Medical School, Newark, NJ, Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, James J. Peters VA Medical Center, Bronx, NY, Oncology and Hematology of White Plains, Mt Vernon, NY, VA New Jersey Healthcare System, East Orange, NJ, Section of Hematology/Oncology, VA New Jersey Health Care System, East Orange, NJ

Research Funding

Other

Background: Liver cancer is a leading cause of death. Lack of data exists on palliative care in this group, and care varies by location. We aim to determine if there are differences in palliative care for patients (pts) with liver cancer by VA site. Methods: In an IRB approved protocol, we reviewed medical records of pts at 2 VA medical centers (S1, S2) with liver cancer, who were seen by Palliative Care between 2006 and 2012. Veterans were compared by 1) demographics: Karnofsky performance status > 50 (KPS), marital status, DNR/DNI, 2) palliative intervention: goals of care discussion, referrals to psychology and PT/OT, and 3) outcomes: ED visit within 1 month (mo) of death, ED visit within 6 mo of death, ICU within 30 days of death, and hospice as site of death, time from diagnosis to palliative care, and time from DNR to death. Chi-square, Fisher’s Exact, and T-test were performed with Stata. Results: here were 82 men, 30 from S1 and 52 from S2, median age 61 (35-87) and 63 (54-88) yrs, respectively. Pts were Caucasian 30 (36%), African American 47 (57%), and other 5 (0.1%). Cancer stages were locoregional 15 (50%), metastatic 13 (43%), and unknown 2 (0.1%) at S1 and 28 (54%), 20 (38%), 5 (0.1%) at S2. Differences were seen in KPS > 50: (S1, S2) [10 (33%), 15(29%) p = 0.010], married: (S1, S2) [7 (23%), 24(46%) p = 0.024], DNR/DNI: (S1, S2) [19 (63%), 13(25%), p = 0.001]. Regarding palliative intervention: goals of care discussion (S1, S2) [26 (87%), 44 (85%), p = 0.044], referral to psych (S1, S2) [16 (53%), 42 (81%) p = 0.014], referral to PT/OT (S1, S2) [17 (57%), 15 (29%), p = 0.007]. Finally in regards to outcome: ED visit within 1 mo of death (S1, S2) [7 (23%), 31 (60%), p = 0.001], ED visit within 6 mos of death (S1, S2) [18 (56%), 35 (67%) p = 0.031], ICU within 30 days of death (S1, S2) [0 (0%), 9 (17%) p = 0.019}, and hospice as site of death (S1, S2) [19 (63%), 21 (40%), p < .0001]. Other key differences included median number of days from diagnosis to initial palliative care consult (S1, S2) [97, 39, p = 0.001] and median number of days from DNR to death (S1, S2) [33, 14, p = 0.001]. Conclusions: Results show there are site-specific differences between VA medical centers. These data may be important in the comparison of other centers and provide a baseline for future studies.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2016 Palliative and Supportive Care in Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Evaluation and Assessment of Patient Symptoms and Quality of Life,Integration and Delivery of Palliative Care in Cancer Care

Sub Track

Evaluation methods/approaches

Citation

J Clin Oncol 34, 2016 (suppl 26S; abstr 75)

DOI

10.1200/jco.2016.34.26_suppl.75

Abstract #

75

Poster Bd #

B10

Abstract Disclosures

Similar Abstracts

First Author: Sarah Lee

Abstract

2018 Palliative and Supportive Care in Oncology Symposium

Examining the intersection of palliative care, hospice, and concurrent care in Veterans Affairs (VA).

First Author: Kathleen Elizabeth Bickel

Abstract

2021 ASCO Quality Care Symposium

Supportive care services and goals of care in early phase clinical trials (EP-CTs).

First Author: Megan Healy

First Author: Vinit Singh